Balancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approach
about
Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findings.Effect of extended-duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis.Thrombosis in inflammatory bowel disease: are we tailoring prophylaxis to those most at risk?Duration of anticoagulant therapy in pediatric venous thromboembolism: Current approaches and updates from randomized controlled trials.
P2860
Balancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approach
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Balancing risk and benefit in ...... l design and analytic approach
@ast
Balancing risk and benefit in ...... l design and analytic approach
@en
type
label
Balancing risk and benefit in ...... l design and analytic approach
@ast
Balancing risk and benefit in ...... l design and analytic approach
@en
prefLabel
Balancing risk and benefit in ...... l design and analytic approach
@ast
Balancing risk and benefit in ...... l design and analytic approach
@en
P2093
P2860
P356
P1476
Balancing risk and benefit in ...... l design and analytic approach
@en
P2093
A C Spyropoulos
A G G Turpie
Antithrombotic Trials Leadership and Steering (ATLAS) Group
C M Kessler
J L Halperin
J M Kittelson
N A Goldenberg
N R Cutler
P2860
P304
P356
10.1111/JTH.12324
P50
P577
2013-08-01T00:00:00Z